Evidence map›Paper›PMID 32342312›Full record

ArticleDoklady. Biochemistry and biophysics2020

Genome Editing As an Approach to the Study of in Vivo Transcription Reprogramming.

Y Y Silaeva, V A Kalmykov, E A Varlamova, E N Korshunov, D S Korshunova, M V Kubekina, A A Shtil, I B Roninson, A V Deykin

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Y Y SilaevaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. silaeva@genebiology.ru.
V A KalmykovInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
E A VarlamovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
E N KorshunovInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
D S KorshunovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
M V KubekinaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
A A ShtilInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
I B RoninsonInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
A V DeykinInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. alexei@deikin.ru.
Institute of Gene Biology · RUMinistry of Health of the Russian Federation · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CDK8-mediated transcriptional reprogramming is essential for an extensive gene expression. Constitutive knockouts of the cdk8 gene are lethal at the morula stage. For modeling transcriptional reprogramming in an adult organism, we investigated the possibility to attenuate the CDK8 kinase activity with a F97G mutation in exon 3 of the cdk8 gene. According to preliminary experimental data, this mutation should lead to a decrease in CDK8 kinase activity. To edit the genome of laboratory mice, the CRISPR/Cas9 technology was used, in which the introduction of a double-stranded gap occurred at a distance of 128 nucleotide pairs from the planned site of the introduced mutation. To introduce the mutation, a matrix for homologous repair was used as part of plasmid DNA, with homologous arms 903 and 484 bp in the 5'-3' region from the point of double-stranded rupture, respectively. As a result, mice with site-specific target mutations in exon 3 of the cdk8 gene were obtained. We for the first time demonstrated a high efficacy of the mutation 128 bp apart from the site of double-strand break. Viable animals with the F97G mutation in the catalytic domain of CDK8 kinase were obtained for the first time. The resulting cdk8 mutant mice will be used in subsequent studies to simulate the processes involving transcription reprogramming.

Indexed as

GenomeRNA, Guide, CRISPR-Cas SystemsTranscription, GeneticAnimalsCatalytic DomainCRISPR-Cas SystemsCyclin-Dependent Kinase 8ExonsGene EditingHeterozygoteMaleMiceMice, Inbred C57BLMice, Inbred CBAMutationOligonucleotidesCdk8 protein, mouseCyclin-Dependent Kinase 8OligonucleotidesRNA, Guide, CRISPR-Cas SystemsCDK8 protein kinaseCRISPR/Cas9genetically modified animalsmammalian genome editing

Identifiers

PMID32342312
OpenAlexW3019062241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.